Finding genes discriminating smokers from non-smokers by applying a growing self-organizing clustering method to large airway epithelium cell microarray data

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 111-116

  Shahdoust, Maryam ^a   Hajizadeh, Ebrahim ^a   Mozdarani, Hossein ^a,b   Chehrei, Ali ^a,b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cigarette smoking; Gene expression; Growing self; Lung cancer; Microarray; Organizing maps

Indexed keywords

EID: 84877110577     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.111     Document Type: Article

References (59)

1. Alahakoon D, Halgamuge SK, Srinivasan B (2000). Dynamic self-organizing maps with controlled growth for knowledge discovery. IEEE, 11, 601-14.
2. Amit D, Hochberg A (2012). Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. Int J Clin Exp Med, 5, 296-305.
3. Beane J, Liu G, Sebastiani P, et al (2007). Reversible and permanent effect of tobacco smoke exposure on airway epithelium gene expression. Genome Bioogy, 8, 201.
4. Brendan JC, Harvey B, Heguy A, et al (2006). Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human Airway epithelium of cigarette smokers. Cancer Res, 66, 10729-39.
5. Brigelius-flohe R, Müller M, Lippmann D, Kipp AP (2012). The yin and yang of Nrf2-regulated selenoproteins in carcinogenesis. IJCB, 10, 1155.
6. Boyle J, Gumus Z, Kacker A, et al (2010).Transcriptome effects of cigarette smoke on the human oral mucosal. Cancer Prev Res, 3, 264-78.
7. Chao CH, Berthiller J, Zhang Z, et al (2006). polymorphism and the risk of Lung, bladder, and colorectal NAD(P)H:quinone oxidoreductase 1 (NQO1) pro187Ser polymorphism and the risk of lung, bladder, and colorectalcancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15, 978-87.
8. Cote M, Yoo W, Wenzlaff A, et al (2009). Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 30, 626-35.
9. Eom S, Kim S, Zhang Y, et al (2009). Influence of NQO1,ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control, 20, 137-45.
10. Franklin WA, Gazdar AF, Haney J, et al (1997). Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest, 100, 2133-7.
11. Golub T, Slonim D, Tamayo P, et al (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-7.
12. Getz G, Domany E, Levine E (2000). Coupled two-way clustering analysis of gene microarray data. PNAS, 97, 12079-84.
13. Gebel S, Bosio A, Gerstmayer B, et al (2004). Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. Carcinogenesis, 25, 169-78.
14. Guo M, Hooker C, House M, et al (2004). Promoter hypermethylation of resected bronchial margins:a field defect of changes? Clin Cancer Res, 10, 5131-6.
15. Guan P, He M, Huang D, et al (2009). Lung cancer gene expression database analysis incorporating prior knowledge with support vector machine-based classification method. J Exp Clin Cancer Res, 28, 103.
16. Guo S, Gao M, Li X, et al (2012). Lack of association between NADPH quinone oxidoreductase 1 (NQO1)gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One, 7, 1371.
17. Hallberg J, Dominicus A, Eriksson U, et al (2008). Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med, 77, 486-90.
18. Hibi K, Borges M, Westra WH, et al (1999). PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol, 155, 711-5.
19. Hsu A, Tang S, Halgamuge S (2003). An unsupervised hierarchical dynamic self-organizing approach to cancer class discovery and marker gene identification in microarray data. Bioinformatics, 19, 2131-40.
20. Hsu A (2003). Notes and usage of JAVA software: GSOMPak. Available at http://www.mame.mu.oz.au.
21. Hsu A, Halgamuge S (2003). Enhancement of topology preservation and hierarchical dynamic self-organising maps for data visualization. Int J Approximate Reasoning, 23, 259-79.
22. Hurst-Keneddy J, Chin L, Li L (2012). Ubiquitin C-Terminal hydrolase L1 in tumorigenesis. Biochem Res Int, 10, 1155.
23. Joseph P, Jaiswal AK (1998). NAD(P)H: quinine oxidoreductase 1 reduces the mutagenecity of DNA caused by NADPH: P450 reductase activated metabolities of benzo[a]pyrene quinines. Br J Cancer, 77, 709-19.
24. Kim B, Lee H, Choi H, et al (2007). Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res, 67, 7431-8.
25. Jin Y, Penning TM (2007). Aldo-keto redutases and bioactivation/ detoxification. Annu Rev Phamacol Toxicol, 47, 263-92.
26. Jemal A, Bray F, Cetnter M, et al (2011). Global cancer statistics. Ca Cancer J Clin, 6, 69-90.
27. Kaplan R, Heguy A, Luettich K, et al (2003). Monoallelic upregulation of the imprinted H19 gene in airway epithelium of phenotypically normal cigarette smokers. Cancer Res, 63, 1475-83.
28. Kiyohara Ch, Takayama K, Yoshimasu K, et al (2005). NQO1, MPO, and the risk of lung cancer: a huge review. Genetic In Med, 7, 463-78.
29. Koggalage M (2004). Unsupervised class discovery and feature selection using an improved hierarchical dynamic selforganizing map. NIPS, 3.
30. Kolesar JM, Dahlberg SE, Marsh S, et al (2011). The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer. Oncol Rep, 25, 1765-72.
31. Liu F, Killian JK,Yang M, et al (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene, 29, 3650-64.
32. Liu F, Yu G, Wang G, et al (2012). An NQO1-initiated and p53-independent apoptotic pathway determines the sntitumoreffect of tanshinone IIA against non-small cell lung cancer. PLoS ONE, 7, 42138.
33. Matouk IJ, DeGroot N, Mezan S, et al (2007). The H19 noncoding RNA is essential for human tumor growth. PLOS ONE, 2, 845.
34. Matouk IJ, Mezan S, Mizrahi A, et al (2010). The oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim Biophsy Acta, 1803, 443-51.
35. Miller V, Lin H, Murugan P, et al (2012). Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. Int J Clin Exp Pathol, 5, 278-89
36. Miyata K, Nakayam M, Mizuta S, et al (2007). Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque. Biochem Biophys Res Commun, 365, 207-13
37. Miyazu YM, Miyazawa K, Kurimoto N (2005). Telomerase expression in noncancerous bronchial epithelia is possible market of early development of lung cancer. Cancer Res, 65, 9623-27.
38. Muzio G, Maggiora M, Paiuzzi E, et al (2011). Aldehyde dehydrogenases and cell proliferation. Free Radic Biol Med, 52, 735-46.
39. Nacht M, Dracheva T, Gao Y, et al (2001). Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci USA, 98, 15203-8.
40. Nagaraj NS, Beckers S, Mansah JK, et al (2006). Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett, 165, 182-94.
41. Orr K, Shi Zh, Brown W, et al (2011). Potential prognostic marker ubiquitin carboxyl-terminal hydrolase -L1 does not predict patient survival in non-small cell lung carcinoma. J Exp Clin Cancer Res, 30, 79.
42. Powel CA, Klares S, OCannor G, et al (1999). Loss of heterozygosity in epithelium cells obtained by bronchial brushing:clinical utility in lung cancer. Clin Cancer Res, 5, 2025-34.
43. Penning T (2005). AKR1B10: a new diagnostic marker of nonsmall cell lung carcinoma in smokers. Clinical Canser Res, 11, 1687-90.
44. Patel M, Lu L, Zander D, et al (2007). ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer, 59, 340-9.
45. Pickett G, Seagrave J, Boggs S, et al (2010). Effects of 10 cigarette smoke condensates on primary human airway epithelium cells by comparative gene and cytokine expression studies. Toxicol Sci, 114, 79-89.
46. Saldivar S, Wang Y, Zhao H, et al (2005). An association between a Nqo1 genetic polymorphism and risk of lung cancer. Mutation Res, 582, 71-8.
47. Seitz HK, Becker P (2007). Alcohol metabolism and cancer risk. Alcohol Res Health, 30, 38-41.
48. Sullivan J, Spinola M, Dodge M, et al (2010). Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res, 70, 9937-48.
49. Spira A, Beane J, Shah V, et al (2004). Effect of cigarette smoke on the human airway epithelium cell transcriptome. PNAS, 101, 10143-8.
50. Spira A, Beane J, Shah V, et al (2007). Airway epitheilial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nature Medicine, 13, 361-5.
51. Timofeeva M, Kropp S, Sauter W, et al (2010). Genetic polymorphisms of MPO,GSTT1,GSTM1,GSTP1,EPHX1 and NQO1 as risk factors of early-oneset lung cancer. Int J Cancer, 127, 1547-61.
52. Ucar D, Cogle Ch, Zucali J, et al (2008). Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chemico- Biological Interactions, 178, 48-55.
53. Vasiliou V, Nebert DW (2005). Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics, 2, 138-43.
54. Wistuba I, Gazdar A, Wirmani A, et al (1997). Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst, 89, 1366-73.
55. Wenzlaff AS, Bock CH, Cote M, et al (2005). CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis, 26, 2207-12.
56. Woenckhaus M, Klein-Hitpass L, Grepmeier U, et al (2006). Smoking and cancer -related gene expression in bronchial epithelium and non-small-cell lung cancer. J Pathol, 210, 192-204.
57. Wang W, Chiu J, Lin Ch, et al (2007). Reversal of inflammationassociated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int J Cancer, 120, 2019-27.
58. Wei Sh, Liu Z, Zhao H, et al (2010). Single nucleotide polymorphism ADH7 A92G is associated with risk of squamous cell carcinoma of the head and neck. Cancer, 116, 2984-92.
59. Xu W, Zhou Y, Hang X, et al (2012). Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep, 39, 2821-9.